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The  purpose  of  this  systematic  review  is  to  identify,  describe  and  assess  the potential  effectiveness  of
strategies  to respond  to issues  of vaccine  hesitancy  that have  been  implemented  and  evaluated  across
diverse  global  contexts.
Methods: A  systematic  review  of  peer  reviewed  (January  2007–October  2013)  and  grey literature  (up
to  October  2013)  was  conducted  using  a broad  search  strategy,  built  to capture  multiple  dimensions  of
public  trust,  conﬁdence  and hesitancy  concerning  vaccines.  This  search  strategy  was  applied  and  adapted
across  several  databases  and  organizational  websites.  Descriptive  analyses  were  undertaken  for  166 (peer
reviewed)  and  15  (grey  literature)  evaluation  studies.  In addition,  the  quality  of evidence  relating  to  a
series of  PICO  (population,  intervention,  comparison/control,  outcomes)  questions  deﬁned  by  the  SAGE
Working  Group  on  Vaccine  Hesitancy  (WG)  was  assessed  using  Grading  of  Recommendations  Assessment,
Development  and  Evaluation  (GRADE)  criteria;  data  were  analyzed  using  Review  Manager.
Results:  Across  the  literature,  few  strategies  to address  vaccine  hesitancy  were  found  to  have  been  eval-
uated  for impact  on  either  vaccination  uptake  and/or  changes  in  knowledge,  awareness  or  attitude  (only
14%  of  peer  reviewed  and  25%  of  grey  literature).  The  majority  of  evaluation  studies  were based  in  the
Americas  and  primarily  focused  on  inﬂuenza,  human  papillomavirus  (HPV)  and  childhood  vaccines.  In
low-  and  middle-income  regions,  the  focus  was  on diphtheria,  tetanus  and pertussis,  and  polio.  Across
all  regions,  most  interventions  were  multi-component  and  the  majority  of strategies  focused  on  raising
knowledge  and  awareness.  Thirteen  relevant  studies  were used  for the  GRADE  assessment  that  indicated
evidence  of moderate  quality  for the use of  social  mobilization,  mass  media,  communication  tool-based
training  for  health-care  workers,  non-ﬁnancial  incentives  and  reminder/recall-based  interventions.
Overall, our  results  showed  that  multicomponent  and  dialogue-based  interventions  were  most  effec-
tive.  However,  given  the  complexity  of  vaccine  hesitancy  and  the  limited  evidence  available  on  how  it
can  be addressed,  identiﬁed  strategies  should  be  carefully  tailored  according  to the  target  population,
their  reasons  for  hesitancy,  and  the  speciﬁc  context.
©  2015  Published  by  Elsevier  Ltd.  This  is an open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/3.0/).
1. Introduction
The dynamic and challenging period of indecision around
accepting a vaccination – often referred to as “vaccine hesitancy”5
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expressed in this article are those of the authors and do not necessarily represent
the decisions, ofﬁcial policy or opinions of the World Health Organization.
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2 Department of Global Health, University of Washington, Seattle, USA.
3 Member of SAGE Working Group on Vaccine Hesitancy.
4 Members of SAGE Working Group on Vaccine Hesitancy are listed in Appendix.
5 Vaccine hesitancy “refers to delay in acceptance or refusal of vaccines despite
availability of vaccination services. Vaccine hesitancy is complex and context spe-
– is being increasingly studied. Given the growing concern in many
countries about vaccine hesitancy, the Strategic Advisory Group of
Experts (SAGE) Working Group (WG) on Vaccine Hesitancy6 asked
that a review focused on strategies to address hesitancy be under-
taken.
The purpose of this systematic review was to identify strate-
gies that have been implemented and evaluated across diverse
global contexts in an effort to respond to, and manage, issues
of vaccine hesitancy. This review was conducted to inform the
ciﬁc varying across time, place and vaccines. It includes factors such as complacency,
convenience and conﬁdence” (WHO SAGE meeting, October 2014).
6 http://www.who.int/immunization/sage/sage wg vaccine hesitancy apr12/
en/ [accessed 02.02.15].
http://dx.doi.org/10.1016/j.vaccine.2015.04.040
0264-410X/© 2015 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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recommendations of the SAGE WG,  building on the previous review
of determinants of vaccine hesitancy [1].
2. Methods
2.1. Search strategy
For the peer-reviewed literature, the following databases were
searched for the period of January 2007–October 2013: Medline,
Embase, PsychInfo, Cochrane, CINAHL Plus, Web  of Science, LILACS,
Africa-Wide Information (for these, the search range was  2007 to
9 October 2013); IBSS (2007 to 19th July 2013) and IMEMR  (2007 to
10 October 2013). The applied search strategy was  kept deliberately
broad to try to capture the multiple facets of vaccine hesitancy and
incorporated MeSH or equivalent terms [Appendix 1]. References
in relevant papers were searched for further relevant studies.
For grey literature, an open-dated search ending, in October
2013, was conducted across several databases and organiza-
tional websites, which included: OpenGrey, New York Academy
of Medicine, Global Health, National Institute for Health and
Care Excellence (NICE), Department for International Development
(DFID), the Communication Initiative Network and the Polio Com-
munication Initiative Network [see search terms in Appendix 2].
Direct email requests were sent to individuals/organizations iden-
tiﬁed by the SAGE WG.
2.2. Study selection – Part A (Identiﬁcation, scope of literature
and effect of evaluated interventions)
For peer-reviewed literature, studies were included against the
following criteria: (i) contained research on vaccine hesitancy; (ii)
included any of the keywords in the title or abstract: “strateg*”,
“intervent*”, “campaign”, “evaluation”, “approach” or “program*”;
(iii) described or evaluated an intervention addressing hesitancy
and reported a measure of the primary outcome, i.e. indicating a
change in vaccination uptake or the secondary outcome, i.e. indi-
cating a change in knowledge/awareness and/or attitudes; (iv)
published between January 2007 and October 2013; (v) pertaining
to any vaccines and vaccination programmes; (vi) published in any
of the six ofﬁcial UN languages (Arabic, Chinese, English, French,
Russian and Spanish).
Grey literature was selected based on the following inclusion
criteria: (i) contained any of the keywords
“immunisation/immunization”, “vaccine”, “vaccination”, “strat-
egy”, “intervention”, “evaluation”, “hesitancy”, “refusal”, “trust”,
“conﬁdence”, “acceptance”, “engagement”, “anxiety”, “con-
cern”, “distrust”, “barrier”, “rejection”, “fear”; (ii) published
anytime up to October 2013; (iii) English only. Literature was
excluded if it was: (i) about non-human vaccines or vaccines
not currently available (e.g. HIV); (ii) related to research and
development of vaccines (e.g. efﬁcacy trials) unless explicitly
about public trust, conﬁdence, concern or hesitancy.
The screening of titles and abstracts was shared between at
least two authors; a sample of studies was independently coded
by authors to ensure consistency.
2.3. Data extraction
2.3.1. Part A
A data extraction form was developed by the authors and
reviewed by the SAGE WG.  For evaluation studies, information
extracted included details about the speciﬁc hesitancy issue; type
of intervention (dialogue-based, incentive-based, reminder–recall
based or multi-component), the type of participants, setting and
target vaccine; and the ﬁndings related to the outcomes of interest.
2.3.2. Part B (PICO & GRADE) – Study selection, risk of bias &
analysis
The SAGE WG identiﬁed 15 PICO (Population, Intervention,
Comparator, Outcome) questions [2] [Appendix 3] a priori, to exam-
ine population features likely to inﬂuence the effect of different
interventions and to assess the quality of evidence for each PICO
question using GRADE (Grading of Recommendations, Assessment,
Development, and Evaluation) [3]. The primary outcome of inter-
est was  deﬁned as the uptake of all vaccines included in routinely
recommended immunization.
The 15 PICO questions were developed under three intervention
themes: (1) Dialogue-based, (2) incentive-based (non-ﬁnancial),
and (3) reminder–recall. Following an extensive discussion by the
WG at the December 2013 meeting, it was decided to focus on
the impact of single component approaches and exclude multi-
component approaches. However, data were included where a
multi-component intervention provided suitable data to assess the
effect of its individual component parts.
Theme categories for PICO questions:
i) Dialogue-based, including the involvement of religious or tra-
ditional leaders, social mobilization, social media, mass media,
and communication or information-based tools for health-care
workers (HCW);
ii) Incentive-based (non-ﬁnancial), including the provision of
food or other goods to encourage vaccination, and;
iii) Reminder/recall-based, including telephone call/letter to
remind the target population about vaccination.
Evaluated primary studies identiﬁed earlier (Part A) were
included if they provided direct evidence relevant to one or more
PICO questions and reported data for comparison groups. Reasons
for excluding studies are presented in Characteristics of excluded
studies [4].
2.3.3. Assessment of risk of bias
The Effective Public Health Practice Project (EPHPP) qual-
ity assessment tool for quantitative studies [5] was applied to
determine the risk of bias of all eligible studies. Two reviewers
independently conducted the risk of bias assessment and data
extraction; disagreements were settled through discussion.
2.3.4. Data analysis
For studies which included pre- and post-control and interven-
tion groups, only post-data were used to more accurately represent
the effect of the intervention. Outcomes reported varied between
studies, so available data were entered into Review Manager soft-
ware as individual studies. The ﬁxed-effects model was used for
analysis and results reported as risk ratios between intervention
and control groups.
3. Results
3.1. Part A – Identiﬁcation, scope of literature and effect of
evaluated interventions
The search of peer reviewed publications identiﬁed 33023 peer
reviewed articles. After removing duplicates and screening for
inclusion criteria, 1149 articles were included by full-text. Of these,
166 [6–172] evaluated and 983 described, but did not evaluate, an
intervention. Among the evaluated studies included from the peer
reviewed literature, 115 related to Outcome 1, 37 to Outcome 2,
and 14 to both [Fig. 1].
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Fig. 1. Search process ﬂow chart (peer reviewed literature) – Vaccine hesitancy.
The grey literature search identiﬁed 4896 records. After remov-
ing duplicates and screening for inclusion criteria, 59 articles were
included by full text. Of these, 15 evaluated [172–186] and 44 only
suggested an intervention. Among the evaluated studies included
from the grey literature, nine reported on Outcome 1, three on
Outcome 2, and three on both [Fig. 2].
There were a total of 181 articles that evaluated interventions
from the peer reviewed and grey literature search, combined.
The number of peer reviewed studies evaluating interventions
peaked in 2011 (at 32 studies) and has remained relatively stable
since (28 in 2012 and 25 in 2013) [Fig. 3].
Very few evaluated interventions were identiﬁed in the grey lit-
erature with one or two articles annually at most from 1996 to 2012.
In 2013, eight relevant articles (47% of those identiﬁed through the
grey literature search) were found [Fig. 4].
Across all the literature reviewed (1208 articles), only ﬁve (0.4%)
used the actual term ‘hesitancy’ or ‘hesitant’ with reference to
vaccines/vaccination [94,173–176]. These were all found in the
peer-reviewed literature and were all published in 2013. Only one
of these articles evaluated an intervention. This intervention was
carried out in AMR  and focused on childhood vaccines, targeting
vaccine hesitant parents using a multi-component strategy that
focused on education techniques. More often articles used terms
such as “refusal”, “distrust” and “acceptance” to discuss vaccination
behaviour. This reﬂects the relative newness of the term “hesi-
tancy”.
The majority (58%) of evaluation studies in the peer reviewed
and grey literature were based in AMR7 (110/1898), and primar-
ily focused on inﬂuenza, HPV and childhood vaccines. In low- and
middle-income regions, particularly SEAR and AFR, the focus was
on Diphtheria, Tetanus, Pertussis (DTP) and polio. All regions had
evaluated studies anticipating or researching acceptance of the
newly introduced HPV vaccine.
7 The World Health Organization (WHO) divides the world into six WHO  regions,
for  the purposes of reporting, analysis and administration: WHO  African Region
(AFR), WHO  Region of the Americas (AMR), WHO  South-East Asia Region (SEAR),
WHO  European Region (EUR), WHO  Eastern Mediterranean Region (EMR) and WHO
Western Paciﬁc Region (WPR).
8 The total number of articles is more than (n = 166) (peer reviewed) and (n = 15)
(grey literature) as some articles report on more than one WHO  region.
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Fig. 2. Search process ﬂow chart (grey literature) – Vaccine hesitancy.
Most interventions (primarily in AMR  and EUR) targeted par-
ents, health-care workers (HCWs) and the local community.
Interventions in the grey literature from AFR largely focused on
the local community and religious leaders.
When mapped against the SAGE WG model of determinants
of vaccine hesitancy [Appendix 4], interventions addressing indi-
vidual and social group inﬂuences, particularly knowledge and
awareness raising, were most common in both the peer reviewed
and grey literature (157/341, 46%). Vaccine delivery and the role
of the HCWs were the primary focus of vaccine and vaccination-
speciﬁc interventions (123/3416, 36%). The engagement of religious
and other community leaders was most commonly used to address
contextual inﬂuences such as religion, culture and gender [Fig. 5].
In both the peer reviewed and grey literature, across all
regions, most interventions (97/127, 76%) were multi-component.
Dialogue-based interventions were common in all regions except
EMR; reminder–recall approaches featured predominantly in
higher-income regions; and incentive-based interventions were
Fig. 3. Evaluated peer reviewed strategies by publication year (2007–2013) and WHO  region (n = 172)*. *Total number of articles is more than (n = 166) as some articles
report  on more than one WHO  region.
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Fig. 4. Evaluated grey literature strategies by publication year (1996–2013) and WHO  region (n = 17)*. *Total number of articles is more than (n = 16) as some articles report
on  more than one WHO  region.
only found in AMR  and AFR (single-component), and SEAR (part
of a multi-component approach).
3.2. Which interventions have been most successful?
The most effective interventions employed multiple strategies.
The interventions with the largest observed increases (>25%) in
vaccine uptake (Outcome 1) were those that (not in order of impor-
tance): (1) directly targeted unvaccinated or under-vaccinated
populations [13]; (2) aimed to increase vaccination knowledge
and awareness [20]; (3) improved convenience and access to
vaccination [116]; (4) targeted speciﬁc populations (e.g. HCW)
[9]; (5) mandated vaccinations or sanction against non-vaccination
[46]; and (6) engaged religious or other inﬂuential leaders to
promote vaccination [177]. The greatest increases (>20%) in knowl-
edge, awareness or attitudes (Outcome 2) were observed with
education initiatives, particularly those embedding new knowl-
edge into routine processes (e.g. hospital procedures), which were
most successful at increasing knowledge and changing attitudes
[105]. For both outcomes, those that tailored interventions to spe-
ciﬁc populations and their speciﬁc concerns were most effective
[23,38].
Fig. 5. Evaluated peer reviewed and grey literature strategies by the SAGE WG model of determinants of vaccine hesitancy (n = 344). *Interventions could address more than
one  determinant of vaccine hesitancy.
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3.3. Which interventions have been least successful?
Interventions associated with a less than 10% increase in uptake
included those that focused on quality improvement at clinics (e.g.
improved data collection and monitoring, extended clinic hours
[8,58], passive interventions (e.g. posters, websites [19,24,41] and
incentive-based interventions using conditional or non-conditional
cash transfers. It must be noted that incentive-based interventions
usually targeted general preventive health and not just vaccination
[96,98]. Lastly, reminder–recall interventions were associated with
variable changes in uptake [57,75,88].
3.4. Part B – PICO & GRADE
Of 129 studies available, only 13 studies met  the inclusion crite-
ria for GRADE evaluation. The methodological quality (risk of bias)
of each is set out in Appendix 5. Further study details are presented
in Appendix 6.
The delivery of interventions varied as did the outcomes. Con-
sequently only one outcome (two studies) for a single vaccine
was pooled; meta-analysis was not feasible for any other outcome
[64,66]. Summary of relative risk ratios (RR) and evidence quality
(GRADE) for each question are presented in Appendix 3. Of the 15
PICO questions, only 10 could be addressed, often with only 1 study
with evidence.
4. Dialogue-based interventions
Eleven studies evaluated by PICO and GRADE deployed
dialogue-based interventions (explained below). There was appre-
ciable variability in the quality of evidence supporting the use of
these interventions and their impact varied considerably, by type
of intervention, by vaccine and by setting.
For polio, the involvement of religious or traditional leaders
in populations with low baseline uptake indicated a large, posi-
tive effect (RR 4.12 [3.99, 4.26]) on vaccine uptake but the evidence
quality was assessed as very low [65] (Nigeria). The grey literature
also reinforced that religious and traditional leader involvement
can have a positive impact [3,5,177,178] as in west and central
francophone African countries, Afghanistan, India and Europe.
Four studies using social mobilization among parents in low-
income settings found a positive effect on measles (RR 1.63 [1.39,
1.91]) [78] (Pakistan), DTP3 (RR 2.17 [1.8, 2.61]) [78] (Pakistan),
DTP1 (RR 1.54 [1.1, 2.15]) [106] (Nigeria), and polio (RR 1050.00
[147.96, 7451.4]) [66] (Pakistan) [64] (India) vaccine uptake. The
quality of evidence for each outcome ranged from moderate
(measles, DTP3), to low (polio) and very low (DTP1). Two  stud-
ies targeting polio vaccination refusals reported large increases in
uptake. In the grey literature, inclusion of social mobilization as a
component appeared to have a positive, albeit varied effect and was
not always quantiﬁed.
Two studies evaluating social media interventions found a
positive effect on uptake for MCV4/Tdap (RR 2.01 [1.39, 2.93])
[102] (Australia) and seasonal inﬂuenza (RR 2.38 [1.23, 4.6]) [157]
(Australia) although the evidence was assessed as low and very low
quality. In the grey literature, one study [178] in Slovenia reported
on the use of social media with other strategies for A(H1N1), how-
ever its effect was not independently measured, achieved low
utilization, and became a source of negative social media rumours.
A study on mass media to target parents with low awareness
of health services found an association with increased uptake of all
routinely recommended vaccines (RR 1.57 [1.4, 1.75]) [179] (India).
The quality of evidence was moderate. Three grey literature studies
reported on the use of mass media for A(H1N1) [178] (Europe), rou-
tine childhood immunization [177] (west and central francophone
African countries) and polio [3] (Afghanistan) but their impact was
not independently measured from other intervention components.
Communication tool-based training for health-care work-
ers had a positive impact on uptake of EPI vaccines (RR 3.09
[2.19, 4.36]) [92] and DTP3 (RR 1.54 [1.33, 1.79]) [79] in India and
Pakistan respectively, among rostered patients; evidence quality
was assessed as moderate and low respectively.
One study [10] (Turkey) assessed the impact of information-
based training for health-care workers on uptake for rostered
patients, with varying results. There was little or no increase in
uptake of DTP/OPV-1 (RR 0.99 [0.93, 1.06]), DTP/OPV-2 (RR 1.04
[0.97, 1.12]), BCG (RR 1.01 [0.95, 1.08]) and measles (RR 1.02 [0.96,
1.09]), a moderate increase in uptake of HepB-2 (RR 1.63 [1.49,
1.79]), HepB-3 (RR 1.89 [1.74, 2.04]) and DTP/OPV-3 (RR 1.42 [1.33,
1.51]), and a substantial increase in uptake of HepB-1 (RR 2.83 [2.6,
3.08]); but the evidence quality was  very low for all.
5. Non-ﬁnancial incentives
The evidence for non-ﬁnancial incentives for par-
ents/communities located in low-income settings (India) was
moderate for a large, positive effect on EPI vaccine uptake (RR 2.16
[1.68, 2.77]) [92].
6. Reminder–recall interventions
Two  studies assessed the impact of reminder–recall interven-
tions in low-income and under-vaccinated populations. The impact
of reminder–recall interventions in low-income settings was  posi-
tive for DTP3 (RR 1.26 [1.13, 1.42]) [146] (Pakistan) with moderate
quality evidence. For settings with low baseline uptake, the effects
were large and positive for scheduled childhood vaccines (RR 3.22
[1.59, 6.53]) [86] (Switzerland) but the quality of evidence was  very
low.
7. Discussion
7.1. Part A – Identiﬁcation, scope of literature and effect of
evaluated interventions
While there has been an increase in the number of articles
on the issue of vaccine hesitancy, of those that include a discus-
sion on interventions or strategies to address hesitancy, few go
as far as evaluating them. Furthermore, the speciﬁc term “vac-
cine hesitancy” has only recently been used and the only evaluated
intervention that explicitly addressed “hesitancy” comes from the
United States.
Overall, many of the interventions were not different from tradi-
tional strategies to increase vaccine acceptance, with the majority
focusing at individual and social group level and interventions
being largely on knowledge and awareness raising. While knowl-
edge and awareness raising strategies are important, they are
inadequate, as evidenced by the ﬁnding that the most effective
interventions used multi-component strategies. Furthermore the
most effective interventions were tailored to speciﬁc populations
and addressing speciﬁc concerns, pointing to the importance of
understanding the drivers of vaccine hesitancy to inform the inter-
ventions.
The increasingly recognized domain of vaccine hesitancy needs
new interventions to address new issues. In particular, the dearth of
interventions identiﬁed in low-income countries needs attention.
7.2. Part B – PICO & GRADE
Despite the few studies available for GRADE and variability in
the quality of the evidence, several interventions showed some
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positive impact on vaccination uptake, including: social mobiliza-
tion, mass media, communication tool-based training for HCW,
non-ﬁnancial incentives, and reminder–recall activities. None of
these interventions were without shortcomings, and given the vari-
ability in context, target population and outcome, the potential
application of these interventions must be cautiously considered
when applying them in different circumstances.
8. Dialogue-based interventions
The impact of religious or traditional leader involvement
in populations with low baseline uptake merits further inves-
tigation and evaluation. This type of intervention is important
as it addresses one of the more difﬁcult determinants of vac-
cine hesitancy, namely, misconceptions and community distrust.
This intervention aligns itself with natural community processes –
seeking out community leaders, and encouraging dialogue across
multiple levels to both inform and inﬂuence. The success of the
intervention could be attributed to the efforts made to understand
the target audience, facilitate open dialogue, and integrate activities
with familiar processes and systems.
The success of social mobilization interventions for popula-
tions refusing polio vaccination could also be attributed to the tar-
geting of, and dialogue with, a clearly deﬁned population. By com-
parison, the social mobilization interventions for measles and DTP
were much less targeted; although positive outcomes appear to be
due to meaningful dialogue at both the group and individual level.
Social media intervention studies suggest that this approach
might work well for those who have already started their vacci-
nation schedule, or who are familiar with social media in other
aspects of their lives. However, there is important evidence that
social media are also very open to exploitation if not managed well.
Also those who initiate vaccination are probably not the most hes-
itant of populations and those with access to social media are not
the most marginalized.
The use of mass media to target populations with low aware-
ness of health services appears to be effective, however, the limited
impact also suggests that there may  be other underlying issues
affecting the impact that need investigation and more tailored sup-
porting interventions.
The provision of communication tool-based training for HCW
generally had a positive effect (for EPI vaccines, DTP3) but the size
of the effect and evidence quality varied. The observations about
this example and mass media suggest that interventions that adopt
a unidirectional (top down) approach to communication, may  be
successful among some individuals and groups, but not all; success
is dependent on the nature and degree of hesitancy.
The impact of information-based training for HCW on uptake
of several vaccines for rostered patients was generally poor. A
possible explanation for these results is that there was no clear
understanding of the underlying reasons for the low vaccination
uptake and as such, the intervention was not appropriately tar-
geted. Nonetheless, the intervention did achieve good success with
HepB (all doses) and DTP/OPV (dose 3); one possible reason for
this is that the HCW exhibited greater conﬁdence but it is not clear
whether this was an issue prior to the intervention.
9. Non-ﬁnancial incentives
The moderate to large effect of non-ﬁnancial incentives for par-
ents/communities located in low-income settings on vaccination
uptake is promising. In this study the target group was very dis-
advantaged and the food-based incentive, so closely linked with
basic survival, was readily received. Furthermore, the baseline
vaccination rates were very low (2%), and more likely to show
greater outcome changes with an intervention. It is possible that
by addressing basic needs, this intervention simultaneously built
conﬁdence and reduced vaccine hesitancy because the target pop-
ulation felt that their other critical needs were being addressed. This
approach could be particularly important for underserved groups.
10. Reminder–recall interventions
Although positive, the relatively low observed effect of
reminder–recall interventions in low-income settings seems to
reﬂect the limitations of using this kind of intervention alone. In
this example, a complex set of issues was identiﬁed in the tar-
get population but the intervention only addressed one of them.
Reminder–recall on its own is not enough to tackle multiple causes
of hesitancy.
11. Limitations
This review may  be subject to publication bias, in that unsuc-
cessful interventions may  be less likely to be documented in either
the peer-reviewed or grey literature. Another reason for the paucity
of relevant studies is that the PICO questions emphasize spe-
ciﬁc, single component strategies, but many evaluated strategies
are neither designed nor presented in this way. Evaluated, multi-
component interventions were identiﬁed but only overall impact
data were presented. Therefore, outcome data for individual strate-
gies to address vaccine hesitancy were not separately available.
12. Conclusion
Overall this review has found that, despite extensive litera-
ture searching, there are (1) few existing strategies that have been
explicitly designed to address vaccine hesitancy; and (2) even fewer
strategies that have quantiﬁed the impact of the intervention (14%
(166/1149) of peer reviewed; 25% (15/59) of the grey literature).
There is also an uneven geographical spread in the available litera-
ture, with most focusing on AMR  and EUR.
Efforts to address issues of hesitancy are disparate. While a
number of interventions did have a positive effect, wide variation
was observed in the effect size between studies, settings and tar-
get populations. In addition, the high level of heterogeneity across
study design and outcomes, coupled with few available studies,
further limited our ability to draw many general conclusions about
the effectiveness of different strategies.
Nonetheless, interventions to increase uptake that are multi-
component and/or have a focus on dialogue-based approaches tend
to perform better. Together, these interventions suggest that taking
a comprehensive approach that targets multiple audiences and lay-
ers of social interaction are more likely to bring positive results. The
evidence for non-ﬁnancial incentives and reminder–recall activ-
ities was  also of good quality, and carries the potential to bring
positive change by addressing the more practical aspects of vacci-
nation.
Vaccine hesitancy is a complex issue and no single strategy will
be able to address it. There are some promising examples using
uptake as a link, but many are incomplete and most are not directly
comparable. One of the greatest drawbacks of the interventions
identiﬁed is that many operate from an assumption-based rather
than an evidence-based approach; appropriate evaluation is also
lacking. On a more positive note, there is a growing body of research
on the determinants of vaccine hesitancy which can help inform
and reﬁne currently used approaches that look promising but have
not yet been fully implemented or evaluated.
Lastly, there is a clear need for more attention to under-
standing and addressing hesitancy at the community and social
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network level – most interventions have historically focused on
addressing individual level issues (e.g. knowledge, awareness) and
vaccine/vaccination speciﬁc concerns (e.g. mode of delivery, vac-
cine risks) despite the large body of literature on the many other
determinants of vaccine hesitancy.
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